If PTX can't summon the numbers to fill a proper trial then they should look to a collaborator in the US. I'm sure there's a big enough cohort over there. Otherwise it's just using up runway. I don't think that the costs of a US based trial would be prohibitively more expensive than Australia.
Ann: Appendix 4E and 2023 Annual Report, page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
